1 – 38 of 38
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Aspects on the Diverse Manifestations of Cystic Fibrosis
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2023
-
Mark
Treatment and long-term outcome in primary nephrogenic diabetes insipidus
(
- Contribution to journal › Article
- 2022
-
Mark
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study
(
- Contribution to journal › Article
-
Mark
Restoring myocardial infarction-induced long-term memory impairment by targeting the cystic fibrosis transmembrane regulator
(
- Contribution to journal › Article
-
Mark
Tartrate resistant acid phosphatase 5 (TRAP5) mediates immune cell recruitment in a murine model of pulmonary bacterial infection
(
- Contribution to journal › Article
-
Mark
MSCs interaction with the host lung microenvironment : An overlooked aspect?
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Genomic and phenotypic evolution of achromobacter xylosoxidans during chronic airway infections of patients with cystic fibrosis
(
- Contribution to journal › Article
- 2020
-
Mark
Ultrasmall TPGS-PLGA Hybrid Nanoparticles for Site-Specific Delivery of Antibiotics into Pseudomonas aeruginosa Biofilms in Lungs
(
- Contribution to journal › Article
-
Mark
Activity of airway antimicrobial peptides against cystic fibrosis pathogens
(
- Contribution to journal › Article
-
Mark
BPI-ANCA is expressed in the airways of cystic fibrosis patients and correlates to platelet numbers and Pseudomonas aeruginosa colonization
(
- Contribution to journal › Article
- 2018
-
Mark
Heparin-binding protein in sputum as a marker of pulmonary inflammation, lung function, and bacterial load in children with cystic fibrosis
(
- Contribution to journal › Article
-
Mark
Increased platelet activation occurs in cystic fibrosis patients and correlates to clinical status
(
- Contribution to journal › Article
- 2017
-
Mark
Survival after lung transplantation for cystic fibrosis in Sweden
(
- Contribution to journal › Article
-
Mark
DNA-fragmentation is a source of bactericidal activity against Pseudomonas aeruginosa
(
- Contribution to journal › Article
-
Mark
On dysregulated inflammation and airway host defense
2017)(
- Thesis › Doctoral thesis (compilation)
- 2016
-
Mark
Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe
(
- Contribution to journal › Article
- 2014
-
Mark
Airway mucus obstruction triggers macrophage activation and matrix metalloproteinase 12-dependent emphysema
(
- Contribution to journal › Article
- 2013
-
Mark
Tomosynthesis in pulmonary cystic fibrosis
(
- Thesis › Doctoral thesis (compilation)
- 2011
-
Mark
Inverse relation between vitamin D and serum total immunoglobulin G in the Scandinavian Cystic Fibrosis Nutritional Study
(
- Contribution to journal › Article
-
Mark
Vitamin D deficiency as a risk factor for cystic fibrosis-related diabetes in the Scandinavian Cystic Fibrosis Nutritional Study
(
- Contribution to journal › Article
-
Mark
From children to young adults: Cystic fibrosis and siblingship A longitudinal study
(
- Contribution to journal › Article
-
Mark
Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis
(
- Contribution to journal › Article
- 2010
-
Mark
Cystic Fibrosis - long term results of a treatment package including preventive physical exercise
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Gender Differences in the Scandinavian Cystic Fibrosis Population
(
- Contribution to journal › Article
-
Mark
Benchmarks for Cystic Fibrosis carrier screening: A European consensus document
(
- Contribution to journal › Scientific review
- 2009
-
Mark
Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods
(
- Contribution to journal › Article
-
Mark
Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Co-morbidity of cystic fibrosis and celiac disease in Scandinavian cystic fibrosis patients
(
- Contribution to journal › Article
- 2007
-
Mark
Immunological aspects on cystic fibrosis lung disease
2007)(
- Thesis › Doctoral thesis (compilation)
- 2004
-
Mark
Monitor – biology
(
- Contribution to journal › Letter
- 2003
-
Mark
Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein (BPI)-autoantibodies
(
- Contribution to journal › Article
-
Mark
Cystic fibrosis patients heterozygous for MASP-2 gene mutation have lowered MASP-2 concentration, without relation to clinical findings
2003) 9th European Meeting on Complement in Human Disease In Molecular Immunology 40(2-4). p.208-208(
- Contribution to journal › Published meeting abstract
- 2002
-
Mark
Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung
(
- Contribution to journal › Article
- 2001
-
Mark
Clinical and genetical studies in cystic fibrosis and pseudohypoaldosteronism
2001)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Aiway Mucins: experimental models for studies of secretions
2001)(
- Thesis › Doctoral thesis (compilation)
- 2000
-
Mark
What makes the interdisciplinary team tick?
2000) XIIIth International Cystic Fibrosis Congress, June 4-8 2000, Stockholm, Sweden(
- Contribution to conference › Other
- 1999
-
Mark
Identification of MUC5B, MUC5AC and small amounts of MUC2 mucins in cystic fibrosis airway secretions
(
- Contribution to journal › Article
- 1991
-
Mark
Islet Cell Cytoplasmic Antibodies (ICA) in Diabetes and Disorders of Glucose Tolerance
(
- Contribution to journal › Article